What are nucleosides used for?

Nucleosides are base molecules used as starting materials for synthesizing nucleotides and phosphoramidites.

What is the difference between nucleosides and nucleotides?

Nucleosides lack phosphate groups, while nucleotides contain one or more phosphates required for enzymatic reactions.

Are nucleosides used directly in enzymatic reactions?

Nucleosides are typically chemically modified before being used in enzymatic workflows.

Can nucleosides be chemically modified?

Yes, modified nucleosides are widely used to introduce structural or functional changes in nucleic acids.

Why is nucleoside purity important?

High purity ensures correct downstream synthesis of nucleotides and phosphoramidites with predictable performance.

Nucleosides - RNA / BOC Sciences

8-Thioguanosine

Description: 8-Thioguanosine is a significant compound exhibiting remarkable capabilities in studying viral infections and cancer. By proficiently curtailing viral RNA and DNA replication, it effectively subdues the menace of virulence, while concurrently impeding the enhancement of nucleic acids within cancerous cells.

CAT: BRP-01861

CAS: 26001-38-7

Molecular Formula: C10H13N5O5S

Molecular Weight: 315.31

Purity: ≥97% by HPLC

Appearance: Off-white to Grey Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C under inert atmosphere

Density: 2.35±0.1 g/cm3 (Predicted)

Melting Point: >216°C (dec.)

Boiling Point: 595.1±60.0°C at 760 mmHg

Application: Adjuvants, Immunologic

InChIKey: KZELNMSPWPFAEB-UMMCILCDSA-N

Solubility: Soluble in DMSO (Slightly)

CanonicalSMILES: C(C1C(C(C(O1)N2C3=C(C(=O)NC(=N3)N)NC2=S)O)O)O

IUPAC Name: 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-sulfanylidene-1,7-dihydropurin-6-one

InChI: InChI=1S/C10H13N5O5S/c11-9-13-6-3(7(19)14-9)12-10(21)15(6)8-5(18)4(17)2(1-16)20-8/h2,4-5,8,16-18H,1H2,(H,12,21)(H3,11,13,14,19)/t2-,4-,5-,8-/m1/s1

Synonyms: 8-Mercaptoguanosine; 8-SH-Guo; 2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-8-mercapto-1H-purin-6(9H)-one; 7,8-Dihydro-8-thioxoguanosine; 8-Mercapto-7,8-dihydroguanosin; 8-Tio-Guanosine; Guanosine, 8-mercapto-; NSC 79216; SQ 12760

1-(a-D-Ribofuranosyl)uracil

Description: 1-(α-D-Ribofuranosyl)uracil is a Uridine, encapsulating an indispensable role in the metabolic processes of carbohydrate derivatives.

CAT: BRP-01862

CAS: 3258-07-9

Molecular Formula: C9H12N2O6

Molecular Weight: 244.20

Purity: ≥97% by HPLC

Appearance: White to Off-white Powder to Crystalline Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.674±0.06 g/cm3 (Predicted)

Melting Point: 202 °C

InChIKey: DRTQHJPVMGBUCF-JBBNEOJLSA-N

CanonicalSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O

IUPAC Name: 1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8+/m1/s1

Synonyms: alpha-D-Uridine; 1-(α-D-ribofuranosyl)uracil; 1-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-α-D-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione; Uracil, 1-α-D-ribofuranosyl-; α-D-Uridine; α-Uridine

N4-Acetyl-2'-O-tert-butyldimethylsilylcytidine

Description: N4-Acetyl-2'-O-tert-butyldimethylsilylcytidine, a formidable chemical compound adept at thwarting RNA viruses, hepatitis C virus included, is a crucial intermediary in the creation of novel nucleotide analogs with the power to curtail RNA replication and viral dissemination. This multifaceted agent is indispensable in the pursuit of new curative medicines designed to counter one of the greatest threats to global health, making it an indispensable cornerstone in modern drug discovery and biomedical inquiry.

CAT: BRP-01864

CAS: 401812-97-3

Molecular Formula: C17H29N3O6Si

Molecular Weight: 399.51

Purity: ≥97% by HPLC

Appearance: White to Off-white Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at RT

Density: 1.28±0.1 g/cm3

InChIKey: FFPMJMDVFALXLQ-NMFUWQPSSA-N

CanonicalSMILES: CC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)O[Si](C)(C)C(C)(C)C

IUPAC Name: N-[1-[(2R,3R,4R,5R)-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide

InChI: InChI=1S/C17H29N3O6Si/c1-10(22)18-12-7-8-20(16(24)19-12)15-14(13(23)11(9-21)25-15)26-27(5,6)17(2,3)4/h7-8,11,13-15,21,23H,9H2,1-6H3,(H,18,19,22,24)/t11-,13-,14-,15-/m1/s1

Synonyms: 2'-TBDMS-Ac-rC; 2'-O-tert-butyldimethylsilyl-N4-Acetyl-cytidine; N-Acetyl-2'-O-[(1,1-dimethylethyl)dimethylsilyl]cytidine; N-Acetyl-2'-O-[dimethyl(2-methyl-2-propanyl)silyl]cytidine

2'-O-tert-Butyldimethylsilyl-N2-isobutyrylguanosine

Description: 2'-O-tert-Butyldimethylsilyl-N2-isobutyrylguanosine, a vital reagent in the biomedical sector, holds immense significance for synthesizing diverse antiviral medications. Its unparalleled structure and mechanism of action contribute significantly to combating viral infections like hepatitis C and HIV.

CAT: BRP-01865

CAS: 182007-86-9

Molecular Formula: C20H33N5O6Si

Molecular Weight: 467.59

Purity: 96%

Appearance: White to Off-white Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at RT

Density: 1.37±0.1 g/cm3 (Predicted)

InChIKey: HKUCCPHGYWSUOP-XWXWGSFUSA-N

CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O[Si](C)(C)C(C)(C)C

IUPAC Name: N-[9-[(2R,3R,4R,5R)-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide

InChI: InChI=1S/C20H33N5O6Si/c1-10(2)16(28)23-19-22-15-12(17(29)24-19)21-9-25(15)18-14(13(27)11(8-26)30-18)31-32(6,7)20(3,4)5/h9-11,13-14,18,26-27H,8H2,1-7H3,(H2,22,23,24,28,29)/t11-,13-,14-,18-/m1/s1

Synonyms: 2'-TBDMS-ibu-rG; 2'-O-TBDMS-rG(ib); 2'-O-(tert-Butyldimethylsilyl)-N-isobutyrylguanosine; Guanosine, 2'-O-[(1,1-dimethylethyl)dimethylsilyl]-N-(2-methyl-1-oxopropyl)-; 2'-O-[Dimethyl(2-methyl-2-propanyl)silyl]-N-isobutyrylguanosine; 2'-O-[(1,1-Dimethylethyl)dimethylsilyl]-N-(2-methyl-1-oxopropyl)guanosine

O6-Methylguanosine

Description: It is a guanine derivative that acts as a modulator of GTPases and modulator-resistant enzymes.

CAT: BRP-01866

CAS: 7803-88-5

Molecular Formula: C11H15N5O5

Molecular Weight: 297.27

Purity: ≥95%

Appearance: White to Pale Yellow Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C under inert atmosphere

Density: 1.98±0.1 g/cm3 (Predicted)

Melting Point: 120 °C

Boiling Point: 721.0±70.0 °C at 760 mmHg

InChIKey: IXOXBSCIXZEQEQ-KQYNXXCUSA-N

Solubility: Soluble in DMSO (Slightly), Methanol (Very Slightly), Water (Slightly)

CanonicalSMILES: COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N

IUPAC Name: (2R,3R,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

InChI: InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7-,10-/m1/s1

Synonyms: 6-O-Methylguanosine; 2-Amino-6-methoxy-9-β-D-ribofuranosyl-9H-purine; 2-Amino-6-methoxypurine Ribonucleoside; 6-Methoxy-9-β-D-ribofuranosyl-9H-purin-2-amine; NSC 66381; O-Methylguanosine; (2R,3R,4S,5R)-2-(2-Amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

9-Ribofuranosyl-9H-Purine-6-thiol

Description: 9-Ribofuranosyl-9H-Purine-6-thiol, utilized as an antiviral therapy to hinder viral replication, has been demonstrated to treat viral infections including, but not limited to, Hepatitis B and HIV. Its selectivity enables the targeted impact on infected CD4 T-helper cells, subsequently leading to a decrease of the viral load while simultaneously heightening the CD4 cell count.

CAT: BRP-01867

CAS: 4988-64-1

Molecular Formula: C10H12N4O4S

Molecular Weight: 284.29

Purity: ≥97% by HPLC

Appearance: Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 2.02±0.1 g/cm3

Boiling Point: 714.7±70.0°C at 760 mmHg

InChIKey: NKGPJODWTZCHGF-VTHZCTBJSA-N

CanonicalSMILES: C1=NC(=S)C2=C(N1)N(C=N2)C3C(C(C(O3)CO)O)O

IUPAC Name: 9-[(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione

InChI: InChI=1S/C10H12N4O4S/c15-1-4-6(16)7(17)10(18-4)14-3-13-5-8(14)11-2-12-9(5)19/h2-4,6-7,10,15-17H,1H2,(H,11,12,19)/t4-,6-,7-,10?/m1/s1

Synonyms: 9H-Purine-6-thiol, 9-ribofuranosyl-; 6H-Purine-6-thione, 3,9-dihydro-9-D-ribofuranosyl-; 6-Mercapto-9β-D-ribofuranosyl-9H-purine; 9-(D-Ribofuranosyl)-3,9-dihydro-6H-purine-6-thione; 9-(D-ribofuranosyl)-9H-purine-6-thiol

Related CAS: 574-25-4 (β-D-configuration)

Uridine 5'-(2-Methylpropanoate)

Description: An impurity of Molnupiravir which is an antiviral drug with promising activity against the SARS-CoV-2 virus.

CAT: BRP-01888

CAS: 886538-48-3

Molecular Formula: C13H18N2O7

Molecular Weight: 314.29

Purity: ≥98%

Appearance: White solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.440±0.06 g/cm3

InChIKey: XVKGAWPWDOKILJ-QCNRFFRDSA-N

CanonicalSMILES: CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=O)NC2=O)O)O

IUPAC Name: [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl 2-methylpropanoate

InChI: InChI=1S/C13H18N2O7/c1-6(2)12(19)21-5-7-9(17)10(18)11(22-7)15-4-3-8(16)14-13(15)20/h3-4,6-7,9-11,17-18H,5H2,1-2H3,(H,14,16,20)/t7-,9-,10-,11-/m1/s1

Synonyms: Molnupiravir Impurity C; Molnupiravir Impurity 7; ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate

3'-O-Methyl-5-methyluridine

Description: 3'-O-Methyl-5-methyluridine, an essential component in the realm of nucleoside investigation, is a remarkably intricate biomedical product. Pivotal to the scientific and healing domains, it finds extensive application in the fabrication of manipulated RNA entities.

CAT: BRP-01889

CAS: 2305415-87-4

Molecular Formula: C11H16N2O6

Molecular Weight: 272.25

Purity: ≥95%

Appearance: White solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.47±0.1 g/cm3

InChIKey: YAKSSRAOGINRKE-FDDDBJFASA-N

CanonicalSMILES: CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OC)O

IUPAC Name: 1-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione

InChI: InChI=1S/C11H16N2O6/c1-5-3-13(11(17)12-9(5)16)10-7(15)8(18-2)6(4-14)19-10/h3,6-8,10,14-15H,4H2,1-2H3,(H,12,16,17)/t6-,7-,8-,10-/m1/s1

Synonyms: 3'-OMe-5-Methyl-U; 1-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione

2',3'-O-Isopropylideneuridine

Description: A useful precursor for the preparation of nucleic acids.

CAT: BRP-01896

CAS: 362-43-6

Molecular Formula: C12H16N2O6

Molecular Weight: 284.27

Purity: 98%

Appearance: White to Off-White Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

Density: 1.376±0.06 g/cm3

Melting Point: 160-165°C

Boiling Point: 426.76 °C at 760 mmHg

Application: A useful precursor for the preparation of nucleic acids.

InChIKey: GFDUSNQQMOENLR-PEBGCTIMSA-N

Solubility: Soluble in Chloroform (Slightly, Heated), DMSO (Slightly), Methanol (Slightly)

CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=CC(=O)NC3=O)CO)C

IUPAC Name: 1-[(3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C12H16N2O6/c1-12(2)19-8-6(5-15)18-10(9(8)20-12)14-4-3-7(16)13-11(14)17/h3-4,6,8-10,15H,5H2,1-2H3,(H,13,16,17)/t6-,8-,9-,10-/m1/s1

Synonyms: 1-((3AR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine-2,4(1H,3H)-dione; Uridine 2',3'-isopropylidine; Uridine 2',3'-acetonide; Uridine, 2',3'-O-(1-methylethylidene)-; Uridine, 2',3'-O-isopropylidene-; 2',3'-Isopropylideneuridine; 2',3'-O-(1-Methylethylidene)uridine; NSC 520038

5'-O-DMT-adenosine

Description: 5'-O-DMT-adenosine is a key building block in oligonucleotide synthesis, where the 5' hydroxyl group of adenosine is protected with a DMT group. This modification allows for controlled synthesis of oligonucleotides and finds extensive use in molecular biology research and biotechnology applications.

CAT: BRP-01897

CAS: 81352-25-2

Molecular Formula: C31H31N5O6

Molecular Weight: 569.61

Purity: ≥95% by HPLC

Appearance: White Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.4±0.1 g/cm3

Melting Point: 145-147 °C

Boiling Point: 812.0±75.0°C at 760 mmHg

InChIKey: KOQFCLKBHJBRTB-BQOYKFDPSA-N

CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O

IUPAC Name: (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]oxolane-3,4-diol

InChI: InChI=1S/C31H31N5O6/c1-39-22-12-8-20(9-13-22)31(19-6-4-3-5-7-19,21-10-14-23(40-2)15-11-21)41-16-24-26(37)27(38)30(42-24)36-18-35-25-28(32)33-17-34-29(25)36/h3-15,17-18,24,26-27,30,37-38H,16H2,1-2H3,(H2,32,33,34)/t24-,26-,27-,30-/m1/s1

Synonyms: 5'-O-DMT adenosine; 5'-O-(4,4'-Dimethoxytrityl)adenosine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-adenosine; (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3,4-diol; 5-O-Dimethoxytrityladenosine

2-Chloro-N6-cyclopentyladenosine

Description: It is a selective adenosine receptor agonist and inhibits angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin signaling pathway.

CAT: BRP-01900

CAS: 37739-05-2

Molecular Formula: C15H20ClN5O4

Molecular Weight: 369.80

Purity: ≥95% by HPLC

Appearance: Off-white to Light Yellow Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C, protect from light

Density: 1.87±0.1 g/cm3 (Predicted)

Boiling Point: 656.1±65.0 °C at 760 mmHg

InChIKey: XSMYYYQVWPZWIZ-IDTAVKCVSA-N

Solubility: Soluble in DMSO, Water

CanonicalSMILES: C1CCC(C1)NC2=C3C(=NC(=N2)Cl)N(C=N3)C4C(C(C(O4)CO)O)O

IUPAC Name: (2R,3R,4S,5R)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

InChI: InChI=1S/C15H20ClN5O4/c16-15-19-12(18-7-3-1-2-4-7)9-13(20-15)21(6-17-9)14-11(24)10(23)8(5-22)25-14/h6-8,10-11,14,22-24H,1-5H2,(H,18,19,20)/t8-,10-,11-,14-/m1/s1

Synonyms: CCPA; 2-Chloro-N-cyclopentyl-adenosine; (2R,3R,4S,5R)-2-(2-chloro-6-(cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 2-chloro-N-cyclopentyl-9-pentofuranosyl-9H-purin-6-amine

2-Chloro-N-[(3-iodophenyl)methyl]-2',3'-O-(1-methylethylidene) Adenosine

Description: 2-Chloro-N-[(3-iodophenyl)methyl]-2',3'-O-(1-methylethylidene) Adenosine, a potent inhibitor of adenosine deaminase, exhibits anti-inflammatory and antitumor activity. Its use in research probes underexplored mechanisms that underlie various clinical conditions, and its therapeutic prospects extend to treating autoimmune disorders and cancers.

CAT: BRP-01902

CAS: 1000980-71-1

Molecular Formula: C20H21ClIN5O4

Molecular Weight: 557.77

Purity: 95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.93±0.1 g/cm3

Boiling Point: 642.5±65.0 °C at 760 mmHg

InChIKey: WCKHUABYZBGHID-SCFUHWHPSA-N

CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC4=C(N=C(N=C43)Cl)NCC5=CC(=CC=C5)I)CO)C

IUPAC Name: [(3aR,4R,6R,6aR)-4-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methanol

InChI: InChI=1S/C20H21ClIN5O4/c1-20(2)30-14-12(8-28)29-18(15(14)31-20)27-9-24-13-16(25-19(21)26-17(13)27)23-7-10-4-3-5-11(22)6-10/h3-6,9,12,14-15,18,28H,7-8H2,1-2H3,(H,23,25,26)/t12-,14-,15-,18-/m1/s1

Synonyms: Adenosine, 2-chloro-N-[(3-iodophenyl)methyl]-2',3'-O-(1-methylethylidene)-; [(3aR,4R,6R,6aR)-6-(2-chloro-6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-2,2-dimethyl-tetrahydro-2H-furo[3,4-d][1,3]dioxol-4-yl]methanol

Guanosine-5'-carboxylic acid

Description: Guanosine-5'-carboxylic acid, a pivotal component in the realm of biomedicine, holds immense importance. Its primary role revolves around the exploration and innovation of antiviral pharmaceuticals, with a specific focus on tackling herpes simplex and varicella-zoster viruses. By serving as a fundamental cornerstone for the synthesis of robust antiviral agents, this compound actively drives significant progress in the treatment landscape of viral ailments.

CAT: BRP-01903

CAS: 15596-14-2

Molecular Formula: C10H11N5O6

Molecular Weight: 297.22

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 2.42±0.1 g/cm3

InChIKey: ASAADZNSXOCOCZ-MXSWDONDSA-N

CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)C(=O)O)O)O)N=C(NC2=O)N

IUPAC Name: (2S,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolane-2-carboxylic acid

InChI: InChI=1S/C10H11N5O6/c11-10-13-6-2(7(18)14-10)12-1-15(6)8-4(17)3(16)5(21-8)9(19)20/h1,3-5,8,16-17H,(H,19,20)(H3,11,13,14,18)/t3-,4+,5-,8+/m0/s1

Synonyms: 1-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-1-deoxy-b-D-ribofuranuronic acid; (2S,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydro-2-furancarboxylic acid; 5'-Guanylsaeure; 1-(2-amino-6-oxo-1,6-dihydro-purin-9-yl)-β-D-1-deoxy-ribofuranuronic acid

Xanthosine

Description: The deamination product of Guanosine. Potential biomarker for detecting radiation exposure. Used in the amplification of DNA isothermal strand displacement.

CAT: BRP-01904

CAS: 146-80-5

Molecular Formula: C10H12N4O6

Molecular Weight: 284.23

Purity: >98.0%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 2.25±0.1 g/cm3

Melting Point: 144-147 °C

Boiling Point: 828.2°C at 760 mmHg

InChIKey: UBORTCNDUKBEOP-UUOKFMHZSA-N

CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)O)NC(=O)NC2=O

IUPAC Name: 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-2,6-dione

InChI: InChI=1S/C10H12N4O6/c15-1-3-5(16)6(17)9(20-3)14-2-11-4-7(14)12-10(19)13-8(4)18/h2-3,5-6,9,15-17H,1H2,(H2,12,13,18,19)/t3-,5-,6-,9-/m1/s1

Synonyms: 1H-Purine-2,6-dione, 3,9-dihydro-9-β-D-ribofuranosyl-; 2,3-Dihydro-2-oxoinosine; 3,9-Dihydro-9-β-D-ribofuranosyl-1H-purine-2,6-dione; 9-β-D-Ribofuranosylxanthine; Inosine, 2,3-dihydro-2-oxo-; NSC 18930; β-D-Ribofuranoside, xanthine-9; Xanthine riboside

m-Topolin riboside

Description: m-Topolin riboside, an esteemed compound employed in the realm of biomedical research, unveils remarkable possibilities in combatting a myriad of ailments, ranging from cancer to neurological disorders. Its intricate composition and distinctive mode of operation engender a plethora of revitalizing attributes, particularly in terms of thwarting tumor progression and safeguarding neural integrity.

CAT: BRP-01907

CAS: 110505-76-5

Molecular Formula: C17H19N5O5

Molecular Weight: 373.36

Purity: ≥98% by HPLC

Appearance: White to off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C, protect from light

Density: 1.71±0.1 g/cm3

Melting Point: 195.6-196.5°C (water)

Boiling Point: 755.0±70.0 °C at 760 mmHg

InChIKey: CMTVBCOBYCGDJR-LSCFUAHRSA-N

CanonicalSMILES: C1=CC(=CC(=C1)O)CNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O

IUPAC Name: (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[(3-hydroxyphenyl)methylamino]purin-9-yl]oxolane-3,4-diol

InChI: InChI=1S/C17H19N5O5/c23-6-11-13(25)14(26)17(27-11)22-8-21-12-15(19-7-20-16(12)22)18-5-9-2-1-3-10(24)4-9/h1-4,7-8,11,13-14,17,23-26H,5-6H2,(H,18,19,20)/t11-,13-,14-,17-/m1/s1

Synonyms: (2R,3R,4S,5R)-2-(6-((3-Hydroxybenzyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; N6-(3-Hydroxybenzyl)adenosine; 6-(3-Hydroxybenzylamino)-9-b-D-ribofuranosylpurine; Adenosine, N-[(3-hydroxyphenyl)methyl]-; N-(3-Hydroxybenzyl)adenosine; N-[(3-Hydroxyphenyl)methyl]adenosine; Meta-topolin riboside; Meta-topolin-9-riboside; N6-(m-Hydroxybenzyl)adenosine

2-Chloroadenosine hemihydrate

Description: 2-Chloroadenosine hemihydrate is a versatile nucleoside analog used in various pharmacological and biochemical studies. Its role as an adenosine receptor agonist makes it valuable for research into adenosine signaling, potential therapeutic applications in cardioprotection, anticancer activity, and anti-inflammatory effects.

CAT: BRP-01908

CAS: 81012-94-4

Molecular Formula: C10H12ClN5O4.1/2H2O

Molecular Weight: 621.39

Purity: 98%

Appearance: Solid powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Melting Point: 160 °C (dec.)

Boiling Point: 717.2 °C at 760 mmHg

InChIKey: WRURCFOLSGPTMO-IZGCVNAISA-N

CanonicalSMILES: C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)Cl)N.C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)Cl)N.O

IUPAC Name: (2R,3R,4S,5R)-2-(6-amino-2-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;hydrate

InChI: InChI=1S/2C10H12ClN5O4.H2O/c2*11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9;/h2*2-3,5-6,9,17-19H,1H2,(H2,12,14,15);1H2/t2*3-,5-,6-,9-;/m11./s1

Synonyms: Adenosine, 2-chloro-, hydrate (2:1); (2R,3R,4S,5R)-2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol hemihydrate; 2-Chloro-D-adenosine hemihydrate; Antibiotic AT 265B hemihydrate; CADO hemihydrate

Related CAS: 146-77-0 (anhydrous)

4-Amino-1-(6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-1,3,5-triazin-2(1H)-one

Description: 4-Amino-1-(6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-1,3,5-triazin-2(1H)-one is an intriguing organic compound that has been extensively researched in the biomedical industry. The compound displays remarkable potential as a DNA topoisomerase inhibitor, a crucial enzyme involved in DNA replication and cell growth. Its distinctive chemical structure is expected to revolutionize drug discovery and development for the treatment of various cancers and microbial infections.

CAT: BRP-01909

CAS: 686300-58-3

Molecular Formula: C11H16N4O5

Molecular Weight: 284.27

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.78±0.1 g/cm3

Boiling Point: 454.4±55.0 °C at 760 mmHg

InChIKey: JPOUCJFPOOJFME-UHFFFAOYSA-N

CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC(=NC3=O)N)CO)C

IUPAC Name: 4-amino-1-[6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-1,3,5-triazin-2-one

InChI: InChI=1S/C11H16N4O5/c1-11(2)19-6-5(3-16)18-8(7(6)20-11)15-4-13-9(12)14-10(15)17/h4-8,16H,3H2,1-2H3,(H2,12,14,17)

Synonyms: 4-amino-1-[2,3-O-(1-methylethylene)pentofuranosyl]-1,3,5-triazine-2(1H)-one

Related CAS: 65370-90-3 (4-Amino-1-[2,3-O-(1-methylethylidene)-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one)

(3aS,4S,6R,6aR)-6-(6-chloro-purin-9-yl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxole-4-carboxylic acid

Description: (3aS,4S,6R,6aR)-6-(6-chloro-purin-9-yl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxole-4-carboxylic acid is a specialized structural analogue of the purine family. It plays an important role in gene response research, and foreseeable areas of application include manufactured oncology therapeutics.

CAT: BRP-01910

CAS: 120355-42-2

Molecular Formula: C13H13ClN4O5

Molecular Weight: 340.72

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, sealed storage, away from moisture

Density: 1.89±0.1 g/cm3

Boiling Point: 582.2±60.0 °C at 760 mmHg

InChIKey: BWQOSYSWEARUOW-MCHASIABSA-N

CanonicalSMILES: CC1(OC2C(O1)C(OC2C(=O)O)N3C=NC4=C3N=CN=C4Cl)C

IUPAC Name: (3aR,4R,6S,6aS)-4-(6-chloropurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole-6-carboxylic acid

InChI: InChI=1S/C13H13ClN4O5/c1-13(2)22-6-7(23-13)11(21-8(6)12(19)20)18-4-17-5-9(14)15-3-16-10(5)18/h3-4,6-8,11H,1-2H3,(H,19,20)/t6-,7+,8-,11+/m0/s1

Synonyms: β-D-Ribofuranuronic acid, 1-(6-chloro-9H-purin-9-yl)-1-deoxy-2,3-O-(1-methylethylidene)-; 1-(6-Chloro-9H-purin-9-yl)-1-deoxy-2,3-O-(1-methylethylidene)-β-D-ribofuranuronic acid

8-Bromo-5'-O-[(4-cyanophenyl)methyl]-2',3'-di-O-(1-methylethylidene)adenosine

Description: 8-Bromo-5'-O-[(4-cyanophenyl)methyl]-2',3'-di-O-(1-methylethylidene)adenosine is a remarkable pharmaceutical compound with anti-inflammatory and immunomodulatory attributes. Potential applications include the research of various inflammatory ailments like rheumatoid arthritand asthma.

CAT: BRP-01911

CAS: 1134156-53-8

Molecular Formula: C21H21BrN6O4

Molecular Weight: 501.33

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.73±0.1 g/cm3

Boiling Point: 712.8±70.0°C at 760 mmHg

InChIKey: XSPCSNCZRVWYLT-NVQRDWNXSA-N

CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C4=NC=NC(=C4N=C3Br)N)COCC5=CC=C(C=C5)C#N)C

IUPAC Name: 4-[[(3aR,4R,6R,6aR)-4-(6-amino-8-bromopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methoxymethyl]benzonitrile

InChI: InChI=1S/C21H21BrN6O4/c1-21(2)31-15-13(9-29-8-12-5-3-11(7-23)4-6-12)30-19(16(15)32-21)28-18-14(27-20(28)22)17(24)25-10-26-18/h3-6,10,13,15-16,19H,8-9H2,1-2H3,(H2,24,25,26)/t13-,15-,16-,19-/m1/s1

Synonyms: 8-Bromo-5'-O-(4-cyanobenzyl)-2',3'-di-O-isopropylidene adenosine; 4-[[(3aR,4R,6R,6aR)-4-(6-amino-8-bromopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methoxymethyl]benzonitrile; Adenosine, 8-bromo-5'-O-[(4-cyanophenyl)methyl]-2',3'-O-(1-methylethylidene)-; 8-Bromo-5'-O-[(4-cyanophenyl)methyl]-2',3'-O-(1-methylethylidene)adenosine; 4-((((3AR,4R,6R,6aR)-6-(6-amino-8-bromo-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methoxy)methyl)benzonitrile

2-Acetamido-6-chloro-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine

Description: 2-Acetamido-6-chloro-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine is a remarkable antiviral compound, showing potential in combating a range of viral infections. By impeding viral replication and augmenting immune responses, this compound manifests as a promising tool against afflictions caused by herpes simplex virus and human immunodeficiency virus (HIV).

CAT: BRP-01913

CAS: 137896-02-7

Molecular Formula: C18H20ClN5O8

Molecular Weight: 469.83

Purity: 95%

Appearance: Light Orange Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 1.63±0.1 g/cm3 (Predicted)

Melting Point: 71-73 °C

InChIKey: OVXYEIBYTBNNFE-LSCFUAHRSA-N

Solubility: Soluble in Acetone, Chloroform, Methanol

CanonicalSMILES: CC(=O)NC1=NC2=C(C(=N1)Cl)N=CN2C3C(C(C(O3)COC(=O)C)OC(=O)C)OC(=O)C

IUPAC Name: [(2R,3R,4R,5R)-5-(2-acetamido-6-chloropurin-9-yl)-3,4-diacetyloxyoxolan-2-yl]methyl acetate

InChI: InChI=1S/C18H20ClN5O8/c1-7(25)21-18-22-15(19)12-16(23-18)24(6-20-12)17-14(31-10(4)28)13(30-9(3)27)11(32-17)5-29-8(2)26/h6,11,13-14,17H,5H2,1-4H3,(H,21,22,23,25)/t11-,13-,14-,17-/m1/s1

Synonyms: N-[6-Chloro-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-2-yl]acetamide; (2R,3R,4R,5R)-2-(2-acetamido-6-chloro-9H-purin-9-yl)-5-(acetoxymethyl)tetrahydrofuran-3,4-diyl diacetate